Crystalys Therapeutics
Latest round
- Series B
Last raised
- Jul 2026
Total raised
- $335M
Investors
- 21
About Crystalys Therapeutics
Crystalys Therapeutics Inc. is a US-based biotechnology company dedicated to developing innovative therapeutics aimed at treating gout and improving patient outcomes. Founded in 2025 and headquartered in San Diego, California, Crystalys Therapeutics Inc. focuses on developing treatments for gout. Founded in 2025 and headquartered in San Diego, California, Crystalys Therapeutics Inc. focuses on developing treatments for gout. Crystalys Therapeutics Inc. was co-founded by James Mackay (CEO), Nihar Bhakta, Ashwin Ram, DeAnne Reid, and BT Slingsby. In July 2026, Crystalys Therapeutics Inc. Crystalys Therapeutics’ lead investigational product is dotinurad, a once-daily oral, highly selective URAT1 inhibitor being developed as a potential second-line treatment for gout. Dotinurad is being evaluated in the Phase 3 RUBY and TOPAZ trials and the Phase 2 AMETHYST trial. Crystalys generates revenue primarily through B2B partnerships, direct sales to healthcare institutions, and potential licensing agreements with pharmaceutical partners, employing transaction structures involving upfront payments and royalties, although specific pricing has not been disclosed.
Who invested in Crystalys Therapeutics
21 investors across 2 rounds
See all investors in Crystalys Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Crystalys Therapeutics
Who invested in Crystalys Therapeutics?
Crystalys Therapeutics has 21 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Crystalys Therapeutics raised?
Crystalys Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Crystalys Therapeutics last raise money?
Crystalys Therapeutics's most recent round on record is a Series B, in Jul 2026.
What does Crystalys Therapeutics do?
Crystalys Therapeutics is a biotechnology company.
Where is Crystalys Therapeutics headquartered?
Crystalys Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Crystalys Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Crystalys Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Crystalys Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.